MHB042C

· Minghui Pharmaceutical (Hangzhou) Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MHB042C, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MHB042C in Patients With Advanced Solid Tumors [Phase 1, Phase 2]